Literature DB >> 16421173

The CAREGENE study: polymorphisms of the beta1-adrenoceptor gene and aerobic power in coronary artery disease.

Johan Defoor1, Kevin Martens, Dominika Zielinska, Gert Matthijs, Hilde Van Nerum, Dirk Schepers, Robert Fagard, Luc Vanhees.   

Abstract

AIMS: The heritability of aerobic power and of the response to physical training has been shown in healthy subjects. beta(1)-Adrenergic receptor (beta(1)AR) function affects exercise performance. This study aims to investigate whether the Ser49Gly and Gly389Arg polymorphisms of the beta(1)AR gene or their haplotypes are associated with aerobic power or its response to physical training in coronary artery disease (CAD). METHODS AND
RESULTS: Nine hundred and thirty-five biologically unrelated Caucasian patients with CAD who had exercised until exhaustion during graded bicycle testing at baseline and after completion of 3 months of exercise training from 1990 to 2001 (n = 1095) were eligible for inclusion in the CAREGENE (CArdiac REhabilitation and GENetics of Exercise performance) study. Polymorphisms were detected using the invader assay (Third Wave Technologiestrade mark, Madison, Wisconsin, USA). Patients with the Gly49Gly genotype had significantly higher covariate-adjusted aerobic power at baseline than those with Ser49Ser and Ser49Gly (P < 0.05). Adjusted aerobic power at baseline was highest in the Ser49-Gly389/Gly49-Gly389 and Gly49-Arg389/Gly49-Arg389 haplotype combinations. Aerobic power increased significantly (P < 0.001) with physical training. There was no association with the effect of physical training.
CONCLUSION: Ser49Gly and haplotype combinations of Ser49Gly and Gly389Arg of the beta(1)AR gene are associated with aerobic power, but not with the response to physical training in patients with CAD included in the CAREGENE study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16421173     DOI: 10.1093/eurheartj/ehi737

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

Review 1.  Genomics and genetics in the biology of adaptation to exercise.

Authors:  Claude Bouchard; Tuomo Rankinen; James A Timmons
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

Review 2.  Pharmacogenomics of beta-adrenergic receptors and their accessory signaling proteins in heart failure.

Authors:  Gerald W Dorn; Stephen B Liggett
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

3.  The Arg16Gly-β(2)-adrenoceptor single nucleotide polymorphism: exercise capacity and survival in patients with end-stage heart failure.

Authors:  Kirsten Leineweber; Ulrich H Frey; Gero Tenderich; Mohammad Reza Toliat; Armin Zittermann; Peter Nürnberg; Reiner Körfer; Winfried Siffert; Gerd Heusch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-08-29       Impact factor: 3.000

4.  Are centenarians genetically predisposed to lower disease risk?

Authors:  Jonatan R Ruiz; Carmen Fiuza-Luces; Amaya Buxens; Amalia Cano-Nieto; Félix Gómez-Gallego; Catalina Santiago; Gabriel Rodríguez-Romo; Nuria Garatachea; José I Lao; María Morán; Alejandro Lucia
Journal:  Age (Dordr)       Date:  2011-09-06

Review 5.  Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases.

Authors:  Kirsten Leineweber; Gerd Heusch
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

6.  Variant on 9p21 strongly associates with coronary heart disease, but lacks association with common stroke.

Authors:  Robin Lemmens; Shérine Abboud; Wim Robberecht; Luc Vanhees; Massimo Pandolfo; Vincent Thijs; An Goris
Journal:  Eur J Hum Genet       Date:  2009-03-25       Impact factor: 4.246

7.  A genetic predisposition score for muscular endophenotypes predicts the increase in aerobic power after training: the CAREGENE study.

Authors:  Tom Thomaes; Martine Thomis; Steven Onkelinx; Robert Fagard; Gert Matthijs; Roselien Buys; Dirk Schepers; Véronique Cornelissen; Luc Vanhees
Journal:  BMC Genet       Date:  2011-10-03       Impact factor: 2.797

8.  Effects of β-Adrenoceptor and Catechol-O-Methyl-Transferase (COMT) Polymorphism on Postoperative Outcome in Cardiac Surgery Patients.

Authors:  Stefan Dhein; Pascal M Dohmen; Matthias Sauer; Julia Tews; Johannes Weickmann; Anne-Kathrin Funkat; Martin Misfeld; Michael A Borger; Friedrich W Mohr
Journal:  Med Sci Monit Basic Res       Date:  2017-05-19

9.  Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study.

Authors:  Ramachandran S Vasan; Martin G Larson; Jayashri Aragam; Thomas J Wang; Gary F Mitchell; Sekar Kathiresan; Christopher Newton-Cheh; Joseph A Vita; Michelle J Keyes; Christopher J O'Donnell; Daniel Levy; Emelia J Benjamin
Journal:  BMC Med Genet       Date:  2007-09-19       Impact factor: 2.103

10.  Adrenergic Receptor Polymorphism and Maximal Exercise Capacity after Orthotopic Heart Transplantation.

Authors:  Mélanie Métrich; Fortesa Mehmeti; Helene Feliciano; David Martin; Julien Regamey; Piergiorgio Tozzi; Philippe Meyer; Roger Hullin
Journal:  PLoS One       Date:  2016-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.